HOME PRODUCTS SERVICES COMPANY CONTACT FAQ

MAZE protocol

Subscribe to New Research on MAZE protocol

combination of above cpds used in therapy of acute myeloid leukemia

Networked: 3 relevant articles (1 outcomes, 2 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Therapeutics: 15318
- Drug Therapy: 178671
  - Combination Drug Therapy: 9625
    - Antineoplastic Combined Chemotherapy Protocols: 23
      - MAZE protocol: 3
  - Antineoplastic Protocols: 26
    - Antineoplastic Combined Chemotherapy Protocols: 23
      - MAZE protocol: 3
- Clinical Protocols
  - Antineoplastic Protocols: 26
    - Antineoplastic Combined Chemotherapy Protocols: 23
      - MAZE protocol: 3
Heterocyclic Compounds: 60
- 1-Ring Heterocyclic Compounds
  - Pyrimidines: 319
    - Pyrimidine Nucleosides: 41
      - Cytidine: 355
        Azacitidine: 935
        MAZE protocol: 3
- 3-Ring Heterocyclic Compounds
  - Acridines: 28
    - Aminoacridines: 3
      - Amsacrine: 504
        MAZE protocol: 3
Organic Chemicals: 58
- Hydrocarbons: 412
  - Cyclic Hydrocarbons: 3
    - Aromatic Hydrocarbons: 132
      - Aromatic Polycyclic Hydrocarbons: 831
        Naphthalenes: 9
        Tetrahydronaphthalenes: 1
        Podophyllotoxin: 391
        Etoposide: 8030
        MAZE protocol: 3
- Aza Compounds: 3
  - Azacitidine: 935
    - MAZE protocol: 3
Nucleic Acids, Nucleotides, and Nucleosides: 1
- Nucleosides: 713
  - Pyrimidine Nucleosides: 41
    - Cytidine: 355
      - Azacitidine: 935
        MAZE protocol: 3
  - Ribonucleosides: 34
    - Cytidine: 355
      - Azacitidine: 935
        MAZE protocol: 3
Polycyclic Compounds: 56
- Aromatic Polycyclic Hydrocarbons: 831
  - Naphthalenes: 9
    - Tetrahydronaphthalenes: 1
      - Podophyllotoxin: 391
        Etoposide: 8030
        MAZE protocol: 3
Carbohydrates: 4088
- Glycosides: 547
  - Glucosides: 155
    - Etoposide: 8030
      - MAZE protocol: 3

Experts

1.	Qian, Xiao-Yan: 1 article (03/2015)
2.	Wu, Zhe: 1 article (03/2015)
3.	An, Jian-Xiong: 1 article (03/2015)
4.	Liu, Cai-Cai: 1 article (03/2015)
5.	Cope, Doris K: 1 article (03/2015)
6.	Williams, John P: 1 article (03/2015)
7.	Tian, Ming: 1 article (03/2015)
8.	Hayes, Jane: 1 article (01/2013)
9.	Lei, Kaichyuan: 1 article (01/2013)
10.	Nejad, Mona: 1 article (01/2013)

Related Diseases

1.	Memory Disorders (Memory Loss) 03/01/2015 - "Both groups improved their latency to reach the platform with the largest difference on the first day (P < 0.01), but without memory deficits in a probe trial for the second water maze protocol. " 01/01/2013 - "A shortened Barnes maze protocol reveals memory deficits at 4-months of age in the triple-transgenic mouse model of Alzheimer's disease."
2.	Alzheimer Disease (Alzheimer's Disease) 01/23/2009 - "We present a 2-day water maze protocol that addresses some of potential confounds present in the water maze when using the aged subjects typical of studies of neurodegenerative disorders, such as Alzheimer's disease. " 01/01/2013 - "A shortened Barnes maze protocol reveals memory deficits at 4-months of age in the triple-transgenic mouse model of Alzheimer's disease."
3.	Neurodegenerative Diseases (Neurodegenerative Disease) 01/23/2009 - "We present a 2-day water maze protocol that addresses some of potential confounds present in the water maze when using the aged subjects typical of studies of neurodegenerative disorders, such as Alzheimer's disease. "